Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Jun 15;7(8):780-4.
doi: 10.1021/acsmedchemlett.6b00169. eCollection 2016 Aug 11.

Design, Synthesis, and Characterization of Sulfamide and Sulfamate Nucleotidomimetic Inhibitors of hHint1

Rachit Shah  1 , Alexander Strom  1 , Andrew Zhou  1 , Kimberly M Maize  1 , Barry C Finzel  1 , Carston R Wagner  1
Affiliations

Design, Synthesis, and Characterization of Sulfamide and Sulfamate Nucleotidomimetic Inhibitors of hHint1

Rachit Shah et al. ACS Med Chem Lett. .

Abstract

Hint1 has recently emerged to be an important target of interest due to its involvement in the regulation of a broad range of CNS functions including opioid signaling, tolerance, neuropathic pain, and nicotine dependence. A series of inhibitors were rationally designed, synthesized, and tested for their inhibitory activity against hHint1 using isothermal titration calorimetry (ITC). The studies resulted in the development of the first small-molecule inhibitors of hHint1 with submicromolar binding affinities. A combination of thermodynamic and high-resolution X-ray crystallographic studies provides an insight into the biomolecular recognition of ligands by hHint1. These novel inhibitors have potential utility as molecular probes to better understand the role and function of hHint1 in the CNS.

Keywords: CNS; ITC; central nervous system; hHint1; human histidine triad nucleotide binding protein 1; isothermal titration calorimetry.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing financial interest.

Figures

Figure 1
Figure 1
(a) Chemical structures of the hHint1 substrates (compounds 1 and 2) and a previously reported hHint1 inhibitor (compound 3). (b) Design of the new generation hHint1 inhibitors with an acyl-sulfamate or sulfamide backbone to improve solubility and potency over compound 3.
Scheme 1
Scheme 1
Reagents and conditions: (i) NH2SO2Cl, DMA, 85%; (ii) 22, DBU, DMF 55%; (iii) 80% aq. TFA quant.
Scheme 2
Scheme 2
Reagents and conditions: (i) chloroacetaldehyde, NaOAc 0.1 M, pH 6.5, 40 °C, 30%; (ii) NH2SO2Cl, DMA, 85%; (iii) 22, DBU, overnight, 55%; and 80% aq. TFA, 1 h quant.
Scheme 3
Scheme 3
Reagents and conditions: (i) MTPI, THF, −70 °C for 30 min and then RT for 4 h 92%; (ii) NaN3, DMF, RT overnight, 55%; (iii) triphenyl phosphine/aq dioxane, triethylamine, 50 °C, 3 h, 54%; (iv) NH2SO2NH2, 1,4-dioxane reflux for 2 h; and 4 N NaOH/MeOH for 2 h, 33%; (v) 22, DBU in DMF, overnight, 55%; and 80% aq. TFA, 1 h quant.
Figure 2
Figure 2
High-resolution X-ray crystal structure analysis of AMP (yellow; pdb: 3TW2) and overlaid with the compound 7 (cyan) in interaction with hHint1 (blue; pdb: 5I2E) complex. (A) H-bond interaction of the sugar and side chain are shown in dotted black lines. (B) Different orientations of isoleucine side chains observed in the hydrophobic nucleotide-binding pocket for AMP and compound 7 bound hHint1 structure is shown in yellow and blue, respectively.
See this image and copyright information in PMC

References

    1. Liu Q.; Puche A. C.; Wang J. B. Distribution and expression of protein kinase C interactive protein (PKCI/HINT1) in mouse central nervous system (CNS). Neurochem. Res. 2008, 33, 1263–1276. 10.1007/s11064-007-9578-4. - DOI - PubMed
    1. Garzón J.; Herrero-Labrador R.; Rodríguez-Muñoz M.; Shah R.; Vicente-Sánchez A.; Wagner C. R.; Sánchez-Blázquez P. HINT1 protein: a new therapeutic target to enhance opioid antinociception and block mechanical allodynia. Neuropharmacology 2015, 89, 412–423. 10.1016/j.neuropharm.2014.10.022. - DOI - PubMed
    1. Chou T. F.; Baraniak J.; Kaczmarek R.; Zhou X.; Cheng J.; Ghosh B.; Wagner C. R. Phosphoramidate pronucleotides: a comparison of the phosphoramidase substrate specificity of human and Escherichia coli histidine triad nucleotide binding proteins. Mol. Pharmaceutics 2007, 4, 208–217. 10.1021/mp060070y. - DOI - PubMed
    1. Wang J.; Fang P.; Schimmel P.; Guo M. Side chain independent recognition of aminoacyl adenylates by the Hint1 transcription suppressor. J. Phys. Chem. B 2012, 116, 6798–6805. 10.1021/jp212457w. - DOI - PMC - PubMed
    1. Zhou X.; Chou T. F.; Aubol B. E.; Park C. J.; Wolfenden R.; Adams J.; Wagner C. R. Kinetic mechanism of human histidine triad nucleotide binding protein 1. Biochemistry 2013, 52, 3588–3600. 10.1021/bi301616c. - DOI - PMC - PubMed